Matthew Nelson

Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.

Change Healthcare Engagement Solutions, Inc. provides healthcare cost transparency solutions. It offers Healthcare Transparency Index that shows medical procedures with high costs and price variances. The firm’s solutions enable consumers to better understand and utilize their healthcare benefits; make informed healthcare purchasing decisions based on quality, cost, and convenience; and manage out-of-pocket responsibility and realize savings. Its solutions also enable users to engage alerts that show savings opportunities, and help take advantage of company health and wellness programs; educate health plan enrollees; and leverage investment with third-party decision support tools. The company was founded by Christopher Parks in 2007 and is headquartered Nashville, TN.

Agilis Biotherapeutics LLC operates as a biotechnology company. It focuses on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. The company was founded in 2013 and is headquartered in Cambridge, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

AccentCare, Inc. engages in the provision of home health care services. Its services include personal care services, hospice care, private duty nursing, and care management. The company was founded by Scott Brogi, Robert Prosek, Joseph I. Davis, and Janet M. Biski and is headquartered in Dallas, TX.

Culligan International Co. provides water treatment products and services. The firm specializes in water softener & filter, commercial filtration, reverse osmosis, bottled water delivery and water technology. The company was founded by Emmett Joseph Culligan in 1936 and is headquartered in Rosemont, IL.

University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT.

Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA.

Akashi Therapeutics Inc is a clinical stage biopharmaceutical company based in Cambridge, MA with subsidiaries in the United States. The private company has been granted orphan designation for DMD in both the US and Europe. The American company's mission is to develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases. Akashi is developing a cocktail of medications with the goal of transforming Duchenne from a 100% fatal, aggressive muscle-wasting disease to a chronic, manageable condition. The application of HT-100 to DMD and other fibrotic diseases is based on pioneering work by Dr. Mark Pines at the Volcani Institute. Dosing and new patient enrollment in the phase 1b/2a clinical program have been suspended. The company was founded by leading patient organizations and biotechnology industry veterans and is managed by a seasoned team of drug development experts. The company was founded by Marc B. Blaustein, Thomas C. Wicka.

Ned Biosystems, Inc. is a clinical-stage company based in Cambridge, MA. The company is focused on developing cancer treatments with the goal of providing uncommon therapies that help patients achieve "No Evidence of Disease."

Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA.

CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago.

Guide Therapeutics, Inc. develops biophotonic technology platform for the early detection of disease that leads to cancer. The company was founded by James Dahlman and Cory Sago and is headquartered in Tucker, GA.

Ellodi Pharmaceuticals engages in the provision of pharmaceutical services. It is dedicated to the clinical development of APT-1011, a novel therapy in Phase 3 development for the treatment of Eosinophilic Esophagitis (EoE) spun-out of Adare Pharmaceuticals (Adare). The company is headquartered in the United States.

Wilco Holdco, Inc. operates as a healthcare company, specializing in outpatient rehabilitation and adjacent healthcare services. The company is headquartered in Bolingbrook, IL.